Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma
暂无分享,去创建一个
Baoyu He | W. Chao | Meiyu Dai | Baoyu He | Shengming Dai | Shao-jun Chen | Wei Chao | Shengming Dai | Jianchao Zeng | Xiaoli Chen | Yujie Huang | Kaifeng Deng | Zhizhuo Huang | Jinwan Li | Meiyu Dai | Shaojun Chen | Haixin Huang | Xiaoli Chen | Jinwan Li | Zhizhuo Huang | Haixin Huang | Kaifeng Deng | Yujie Huang | Jianchao Zeng | Shaojun Chen
[1] Jingxuan Shi,et al. miR‐1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K‐ras in nasopharyngeal carcinoma , 2015, International journal of experimental pathology.
[2] Z. Zeng,et al. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1 , 2016, Oncotarget.
[3] Qiang Wu,et al. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma. , 2016, Cancer biomarkers : section A of Disease markers.
[4] Z. Zeng,et al. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC , 2015, Oncotarget.
[5] Jie Yang,et al. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. , 2016, Cancer biomarkers : section A of Disease markers.
[6] Z. Zeng,et al. Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma , 2016, Oncotarget.
[7] Yaoyong Lu,et al. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma , 2016, Tumor Biology.
[8] P. Shueng,et al. Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma , 2011, Radiation oncology.
[9] Z. Zeng,et al. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma , 2016, Tumor Biology.
[10] Q. Lu,et al. The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma , 2016, Tumor Biology.
[11] Hui-Yun Wang,et al. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma , 2016, Cell Death and Disease.
[12] Akhil Varshney,et al. Non‐coding RNAs: biological functions and applications , 2015, Cell biochemistry and function.
[13] H. Yao,et al. Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value , 2015, BioMed research international.
[14] Z. Zeng,et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma , 2015, Oncotarget.
[15] S. Tsao,et al. Downregulation of long non‐coding RNA MEG3 in nasopharyngeal carcinoma , 2017, Molecular carcinogenesis.
[16] Z. Zeng,et al. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103 , 2016, Cell Death and Disease.
[17] Junwei Tang,et al. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma , 2015, Cellular Physiology and Biochemistry.
[18] Prognostic Correlations between ABO Blood Group and Pre-Treatment Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy , 2016, PloS one.
[19] Hongwei Pan,et al. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer , 2016, Oncotarget.
[20] Qing-quan Wu,et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma , 2015, Molecular Cancer.
[21] Z. Zeng,et al. Epstein–Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma , 2016, Clinical and Translational Oncology.
[22] Z. Zeng,et al. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis , 2015, Tumor Biology.
[23] Zhifu Sun,et al. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer , 2015, Oncotarget.
[24] Jie Yuan,et al. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer , 2016, Oncotarget.
[25] S. Tsao,et al. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma , 2015, Virologica Sinica.
[26] Sheida Nabavi,et al. Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation , 2016, EBioMedicine.
[27] C. Cavaliere,et al. Epstein–Barr virus infection and nasopharyngeal carcinoma: the other side of the coin , 2015, Anti-cancer drugs.
[28] Xiaoguang He,et al. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. , 2016, Biochemical and biophysical research communications.
[29] J. Tang,et al. Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge. , 2013, Current oncology.
[30] U. Gezer,et al. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? , 2016, Tumor Biology.
[31] C. Gong,et al. Long non‐coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival , 2013, Cancer science.
[32] W. Zhang,et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells , 2016, Oncotarget.
[33] Pelayo Vilar,et al. Nasopharyngeal Carcinoma , 1966 .
[34] A. King,et al. Early detection of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA analysis in a surveillance program , 2013, Cancer.
[35] Jianchun Yu,et al. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. , 2015, World journal of gastroenterology.
[36] O. Miura,et al. Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells , 2014, International Journal of Hematology.
[37] S. Zhang,et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] S. Tsao,et al. Epstein‐Barr virus infection in immortalized nasopharyngeal epithelial cells: Regulation of infection and phenotypic characterization , 2010, International journal of cancer.
[39] Q. Zheng,et al. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A , 2016, Oncotarget.
[40] Xiao Zhu,et al. Long noncoding RNA hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways , 2015, Oncotarget.
[41] Y. Wu,et al. A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls , 2016, Oncogenesis.
[42] S. Kannan,et al. Cell‐free Epstein–Barr virus‐DNA in patients with nasopharyngeal carcinoma: Plasma versus urine , 2016, Head & neck.
[43] Xiaoqiang Guo,et al. Long non-coding RNAs: emerging players in gastric cancer , 2014, Tumor Biology.
[44] Y. Zeng,et al. Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China , 2014, Cancer.
[45] W. Jia,et al. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China. , 2013, American journal of epidemiology.
[46] J. Epstein,et al. Nasopharyngeal carcinoma: current management, future directions and dental implications. , 2008, Oral oncology.
[47] N. Raab-Traub. Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus. , 2015, Current topics in microbiology and immunology.
[48] Ke Chen,et al. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma , 2015, Oncotarget.